Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use

About This Study

The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. The study will also evaluate secondary outcomes, including: post-operative pain rating, length of hospital stay, postoperative antiemetic use, bladder catheterization at discharge, number of post-operative phone calls, and rate of reported side effects of opioid use (nausea/constipation). Study participants will be asked to utilize the validated Brief Pain Inventory (appendix A) scale to assess post-operative pain levels. Based on inpatient post-operative opioid use and number of opioid pills prescribed at discharge, an attempt will be made to develop an algorithm for recommended opioid prescribing patterns.

Conditions Studied

Interventions

• •NOMO Protocol

Eligibility

Inclusion Criteria:

* English-speaking females
* greater than or equal to 18 years old
* scheduled for a urogynecologic procedure at GHS requiring inpatient stay or extended observation.

Exclusion Criteria:

* less than 18 years of age
* non-English speaking patients
* unscheduled urogynecologic surgeries
* patients expected to undergo a simple reconstructive surgery with same-day discharge,
* history of chronic pain
* chronic Lyrica or Celebrex use
* psychiatric disorder, narcotic dependence or narcotic prescription in the past six weeks
* current liver disease
* kidney disease (defined as GFR \<60)
* malignancy
* sulfa allergy

Study Locations (1)